Emotion-Focused therapy tested to prevent diabetes in teens

NCT ID NCT05338944

Recruiting now Prevention Sponsor: University of Manitoba Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether dialectical behavioral therapy (DBT), a type of talk therapy that teaches mindfulness and emotional skills, can help teens with obesity improve their quality of life and manage weight. About 90 teens aged 14-17 who show signs of depression and are at risk for type 2 diabetes will be randomly assigned to DBT plus lifestyle coaching, lifestyle coaching alone, or a control group. The main goal is to see if teens will join and stick with the program.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: dialectical behavioral therapy (DBT) combined with lifestyle coaching
What this could lead to: If it works, this could point toward a new way to help teens manage weight and reduce their risk of type 2 diabetes.
What could go wrong: This is a small, early-stage trial focused on feasibility, not on proving the therapy works. Results may not apply to all teens.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obesity disorder type 2 diabetes mellitus prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREVENTION TYPE2DIABETES

Contacts and locations

Locations

McMaster University
RECRUITING

Hamilton, Ontario, L8S 4L8, Canada
University of Calgary
RECRUITING

Calgary, Alberta, T2N 1N4, Canada
University of Manitoba
RECRUITING

Winnipeg, Manitoba, R3E3P4, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.